Publishing House SB RAS:

Publishing House SB RAS:

Address of the Publishing House SB RAS:
Morskoy pr. 2, 630090 Novosibirsk, Russia

Advanced Search

2019 year, number 2


Georgiy Tsyrenovich DAMBAEV1, Nikolay Anatolevich SHEFER2, Anton Georgievich KONDAUROV2, Vladislav Mikhaylovich GARKUSHA2, Igor Ivanovich ENA2
1Siberian State Medical University of Minzdrav of Russia
2Tomsk Regional Oncology Center
Keywords: рак легких, респираторные осложнения, профилактика, послеоперационная пневмония, lung cancer, respiratory complications, prevention, postoperative pneumonia


The aim of the study was to develop and apply a perioperative complex of preventive measures aimed at reducing the incidence of respiratory complications in patients with operable forms of lung cancer. Materials and methods. The study has been conducted between September 2016 and January 2018. 103 patients with operable forms of lung cancer were treated, with anatomic resection of the lungs or pneumonectomy in the conditions of the oncology department of the Tomsk Regional Oncology Center. All patients in the perioperative period used a developed set of measures aimed at preventing the development of respiratory complications. A retrospective analysis was made of the case histories of 66 patients underwent treatment in cancer department of Tomsk Regional Oncology Center between 2014 and 2016, all patients underwent surgical treatment for lung cancer using standard prevention methods. We compared the incidence and structure of respiratory complications in a group of patients using the developed complex and in the retrospective control group. Results. The analysis of groups of patients revealed statistically significant differences in the number and structure of complications. In patients who developed the prophylactic complex at the stages of treatment, respiratory complications were registered in 4 (3.9 %) cases, while in the retrospective control group, respiratory complications developed in 8 (12.1 %) patients. According to the complications structure, the results also vary, in the group with the developed complex, none of the patients registered postoperative pneumonia while in the control group pneumonia developed in 5 cases and was the cause of death in 3 patients. Conclusion. The use of the developed complex in patients with oncopulmonological profile significantly reduces the incidence of respiratory complications in the postoperative period.